Delivery Order SPE2DB20D3103-SPE2DB25FN8N0
Award Date
5/16/25
Potential Completion Date
5/19/25
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a ceiling value of $3,813.38 and an ultimate completion date of May 19, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a $16,913.70 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the procurement of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a performance period through June 4, 2024. This delivery order is placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the delivery of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with a ceiling value of $13,544.03 and a period of performance through March 29, 2024. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract is for the delivery of Cefepime-Dextrose 2 GM/50 ML medical supplies, with a ceiling value of $1,971.48 and a completion date of September 21, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,821.52, is for the provision of Cefepime-Dextrose 2 GM/50 MLS, a pharmaceutical product. The contract has an ultimate completion date of May 17, 2023 and is a Firm Fixed Price type contract. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,171,074 units of the pharmaceutical product Cefepime-Dextrose 2 GM/50 MLS. The contract has a ceiling value of $3,653.65 and an ultimate completion date of April 5, 2024. This delivery order contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds...
This federal contract award, valued at $1,038.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566449785 CEFEPIME-DEXTROSE 2 GM/50 MLS, a medical product, with a completion date of November 18, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated with a Set-Aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of Cefepime-Dextrose 2 gram/50 milliliter pharmaceutical products, with a ceiling value of $3,443.69 and a performance period through April 5, 2024. This award is a firm fixed price delivery order under a larger indefinite delivery contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,211,439 units of the drug Cefepime-Dextrose 2 grams/50 mL. The firm-fixed-price delivery order has a ceiling value of $14,774.54 and a completion date of October 28, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564404173 - CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product. The contract is a firm fixed price delivery order with a ceiling value of $12,050.53 and a period of performance ending on April 26, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical...